Table of Contents

2019-2024 Global Therapeutic Nuclear Medicines Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Nuclear Medicines Consumption 2014-2024
2.1.2 Therapeutic Nuclear Medicines Consumption CAGR by Region
2.2 Therapeutic Nuclear Medicines Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Nuclear Medicines Consumption by Type
2.3.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2014-2019)
2.4 Therapeutic Nuclear Medicines Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Nuclear Medicines Consumption by Application
2.5.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
2.5.2 Global Therapeutic Nuclear Medicines Value and Market Share by Application (2014-2019)
2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2014-2019)

3 Global Therapeutic Nuclear Medicines by Manufacturers
3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers
3.1.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2019)
3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2019)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers
3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2019)
3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Therapeutic Nuclear Medicines Sale Price by Manufacturers
3.4 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Therapeutic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Nuclear Medicines by Regions
4.1 Therapeutic Nuclear Medicines by Regions
4.1.1 Global Therapeutic Nuclear Medicines Consumption by Regions
4.1.2 Global Therapeutic Nuclear Medicines Value by Regions
4.2 Americas Therapeutic Nuclear Medicines Consumption Growth
4.3 APAC Therapeutic Nuclear Medicines Consumption Growth
4.4 Europe Therapeutic Nuclear Medicines Consumption Growth
4.5 Middle East & Africa Therapeutic Nuclear Medicines Consumption Growth

5 Americas
5.1 Americas Therapeutic Nuclear Medicines Consumption by Countries
5.1.1 Americas Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
5.1.2 Americas Therapeutic Nuclear Medicines Value by Countries (2014-2019)
5.2 Americas Therapeutic Nuclear Medicines Consumption by Type
5.3 Americas Therapeutic Nuclear Medicines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Therapeutic Nuclear Medicines Consumption by Countries
6.1.1 APAC Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
6.1.2 APAC Therapeutic Nuclear Medicines Value by Countries (2014-2019)
6.2 APAC Therapeutic Nuclear Medicines Consumption by Type
6.3 APAC Therapeutic Nuclear Medicines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Therapeutic Nuclear Medicines by Countries
7.1.1 Europe Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
7.1.2 Europe Therapeutic Nuclear Medicines Value by Countries (2014-2019)
7.2 Europe Therapeutic Nuclear Medicines Consumption by Type
7.3 Europe Therapeutic Nuclear Medicines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Nuclear Medicines by Countries
8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2014-2019)
8.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type
8.3 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Therapeutic Nuclear Medicines Distributors
10.3 Therapeutic Nuclear Medicines Customer

11 Global Therapeutic Nuclear Medicines Market Forecast
11.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2019-2024)
11.2 Global Therapeutic Nuclear Medicines Forecast by Regions
11.2.1 Global Therapeutic Nuclear Medicines Forecast by Regions (2019-2024)
11.2.2 Global Therapeutic Nuclear Medicines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Nuclear Medicines Forecast by Type
11.8 Global Therapeutic Nuclear Medicines Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Therapeutic Nuclear Medicines Product Offered
12.1.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Novartis AG
12.2.1 Company Details
12.2.2 Therapeutic Nuclear Medicines Product Offered
12.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Novartis AG News
12.3 China Isotope & Radiation
12.3.1 Company Details
12.3.2 Therapeutic Nuclear Medicines Product Offered
12.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 China Isotope & Radiation News
12.4 Dongcheng
12.4.1 Company Details
12.4.2 Therapeutic Nuclear Medicines Product Offered
12.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Dongcheng News
12.5 Q BioMed
12.5.1 Company Details
12.5.2 Therapeutic Nuclear Medicines Product Offered
12.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Q BioMed News
12.6 Curium Pharmaceuticals
12.6.1 Company Details
12.6.2 Therapeutic Nuclear Medicines Product Offered
12.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Curium Pharmaceuticals News
12.7 Jubilant DraxImage
12.7.1 Company Details
12.7.2 Therapeutic Nuclear Medicines Product Offered
12.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Jubilant DraxImage News
12.8 Lantheus
12.8.1 Company Details
12.8.2 Therapeutic Nuclear Medicines Product Offered
12.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus News
12.9 Spectrum Pharmaceuticals
12.9.1 Company Details
12.9.2 Therapeutic Nuclear Medicines Product Offered
12.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Spectrum Pharmaceuticals News
12.10 Progenics Pharmaceuticals
12.10.1 Company Details
12.10.2 Therapeutic Nuclear Medicines Product Offered
12.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Progenics Pharmaceuticals News
12.11 International Isotopes

13 Research Findings and Conclusion